These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20065208)

  • 1. Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension.
    Todd S; McGuinness B; Passmore AP
    Arch Intern Med; 2010 Jan; 170(1):107. PubMed ID: 20065208
    [No Abstract]   [Full Text] [Related]  

  • 2. Centrally Active ACEIs and cognitive decline.
    Asamura T; Ohrui T; Une K; Furukawa K; Arai H
    Arch Intern Med; 2010 Jan; 170(1):107-8; author reply 108. PubMed ID: 20065207
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.
    Sink KM; Leng X; Williamson J; Kritchevsky SB; Yaffe K; Kuller L; Yasar S; Atkinson H; Robbins M; Psaty B; Goff DC
    Arch Intern Med; 2009 Jul; 169(13):1195-202. PubMed ID: 19597068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors.
    Hebert PL; McBean AM; O'Connor H; Frank B; Good C; Maciejewski ML
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):641-8. PubMed ID: 23620414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan.
    Ohrui T; Matsui T; Yamaya M; Arai H; Ebihara S; Maruyama M; Sasaki H
    J Am Geriatr Soc; 2004 Apr; 52(4):649-50. PubMed ID: 15066094
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive treatment and prevention of dementia].
    Seux ML
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):512-7. PubMed ID: 12555375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is differentiation of ACE inhibitors based on their effects on the brain possible?].
    Unger T
    Fortschr Med; 1994 Dec; 112(34):504-6. PubMed ID: 7843678
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of angiotensin converting enzyme inhibitors on the central nervous system].
    Pasławski L; Braszko J
    Pol Merkur Lekarski; 1999 Mar; 6(33):164-6. PubMed ID: 10365605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Angiotensin-converting enzyme inhibitors prevent dementia in elderly patients with diabetes mellitus?
    Murthy SB; Jawaid A; Shah S; Qureshi SU; Schulz PE
    J Am Geriatr Soc; 2010 Mar; 58(3):613-4. PubMed ID: 20398134
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cognitive functions and hypertension].
    Hanon O; Seux ML; Lenoir H; Latour F; Rigaud AS; Forette F
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):133-9. PubMed ID: 15787305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conversion enzyme inhibitors in the treatment of elderly hypertension patients].
    Amery A
    Verh K Acad Geneeskd Belg; 1991; 53(2):163-85; discussion 185-6. PubMed ID: 1853643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
    Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML
    Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type.
    Bellew KM; Pigeon JG; Stang PE; Fleischman W; Gardner RM; Baker WW
    Alzheimer Dis Assoc Disord; 2004; 18(4):208-13. PubMed ID: 15592132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication].
    Birkenhäger WH; de Leeuw PW; Staessen JA; Wang JG; Forette F; Seux ML
    Ned Tijdschr Geneeskd; 2000 Jul; 144(31):1469-74. PubMed ID: 10941432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of arterial hypertension for the development of dementia].
    Schrader J
    MMW Fortschr Med; 2004 Nov; 146(47):40-2. PubMed ID: 15624656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women.
    Yasar S; Zhou J; Varadhan R; Carlson MC
    Clin Pharmacol Ther; 2008 Jul; 84(1):119-26. PubMed ID: 18231116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.